MelioOne®
Primary Dysmenorrhea (Period Pain)
Pre-clinicalActive
Key Facts
About Meliodays Medical
Meliodays Medical is an early-stage biotech innovator targeting the significant unmet need in menstrual health with its lead product, MelioOne®. This non-hormonal IUD is designed to deliver a sustained, low dose of the pain medication Celecoxib directly to the uterus over two years, aiming to reduce systemic exposure and side effects. The company, which closed an oversubscribed pre-seed round of over €800,000 in early 2025, is currently advancing the prototype through nonclinical development. Meliodays operates at the intersection of Medical Devices and Digital Health with a mission to address the gender health gap through research-backed solutions.
View full company profile